Antibodies in celiac disease: Implications beyond diagnostics

72Citations
Citations of this article
175Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Celiac disease is a multisystemic dietary, gluten-induced autoimmune disorder characterized by the presence of transglutaminase (TG) 2 serum autoantibodies. Distinct autoantibodies targeting members of the TG family (TG2, TG3 and TG6) are found deposited in small-bowel mucosa and in extraintestinal tissues affected by the disease. Serum autoantibodies against other self-antigens also emerge in untreated celiac disease patients. Although villous atrophy and crypt hyperplasia in small-bowel biopsy samples are still the gold standards in diagnostics, celiac disease-specific antibodies are widely used as diagnostic aids. Gluten-induced small-bowel mucosal T-cell response is the cornerstone in the pathogenesis of the disorder, but humoral immunity may also play a central role. This review article is focused on the autoantibodies that occur in the context of celiac disease. The article summarizes the diagnostic utility of different celiac-related antibodies and discusses their roles in the pathogenesis of the disease. © 2011 CSI and USTC. All rights reserved.

Cite

CITATION STYLE

APA

Caja, S., Mäki, M., Kaukinen, K., & Lindfors, K. (2011, March). Antibodies in celiac disease: Implications beyond diagnostics. Cellular and Molecular Immunology. https://doi.org/10.1038/cmi.2010.65

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free